Steven Cohen's AZN Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 569,369 shares of AstraZeneca PLC (AZN) worth $43.68 M, representing 0.07% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 46 quarters.
Based on 13F filings since 2013, Steven Cohen has maintained a long-term strategic position in AZN, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2020, adding 3.75 M shares. Largest reduction occurred in Q4 2022, reducing 3.27 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's AstraZeneca PLC (AZN) Holding Value Over Time
Track share changes against reported price movement
Quarterly AstraZeneca PLC (AZN) Trades by Steven Cohen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2014 | +741,602 | Add 0.00% | 741,600 | $37.15 |
| Q3 2014 | +480,600 | Add 64.81% | 1.22 M | $35.72 |
| Q4 2014 | -47,400 | Reduce 3.88% | 1.17 M | $35.19 |
| Q1 2015 | -1.05 M | Reduce 89.48% | 123,600 | $34.22 |
| Q2 2015 | -123,600 | Sold Out | 123,600 | $0.00 |
| Q4 2016 | +676,000 | New Buy | 676,000 | $27.32 |
| Q1 2017 | -676,000 | Sold Out | 676,000 | $0.00 |
| Q2 2017 | +603,108 | New Buy | 603,108 | $34.09 |
| Q3 2017 | +621,831 | Add 103.10% | 1.22 M | $33.88 |
| Q4 2017 | -299,739 | Reduce 24.47% | 925,200 | $34.70 |
| Q1 2018 | +1.98 M | Add 214.04% | 2.91 M | $34.97 |
| Q2 2018 | -103,489 | Reduce 3.56% | 2.8 M | $35.11 |
| Q3 2018 | -2.04 M | Reduce 72.97% | 757,400 | $39.57 |
| Q4 2018 | -264,842 | Reduce 34.97% | 492,558 | $37.98 |
| Q1 2019 | +1.87 M | Add 378.71% | 2.36 M | $40.43 |
| Q2 2019 | -875,724 | Reduce 37.14% | 1.48 M | $41.28 |
| Q3 2019 | -1.48 M | Sold Out | 1.48 M | $0.00 |
| Q1 2020 | +550,049 | New Buy | 550,049 | $44.66 |
| Q2 2020 | +145,339 | Add 26.42% | 695,388 | $52.89 |
| Q3 2020 | -210,906 | Reduce 30.33% | 484,482 | $54.80 |
| Q4 2020 | +3.75 M | Add 774.81% | 4.24 M | $49.99 |
| Q1 2021 | -685,451 | Reduce 16.17% | 3.55 M | $49.72 |
| Q2 2021 | -1.75 M | Reduce 49.22% | 1.8 M | $59.90 |
| Q3 2021 | +635,065 | Add 35.20% | 2.44 M | $60.06 |
| Q4 2021 | -669,688 | Reduce 27.46% | 1.77 M | $58.25 |
| Q1 2022 | -435,600 | Reduce 24.62% | 1.33 M | $66.34 |
| Q2 2022 | +638,179 | Add 47.85% | 1.97 M | $66.07 |
| Q3 2022 | +2.84 M | Add 144.00% | 4.81 M | $54.84 |
| Q4 2022 | -3.27 M | Reduce 68.01% | 1.54 M | $67.80 |
| Q1 2023 | -1.54 M | Sold Out | 1.54 M | $0.00 |
| Q2 2023 | +329 | New Buy | 329 | $71.57 |
| Q3 2023 | -329 | Sold Out | 329 | $0.00 |
| Q4 2023 | +281,443 | New Buy | 281,443 | $67.35 |
| Q1 2024 | -94,043 | Reduce 33.41% | 187,400 | $67.75 |
| Q2 2024 | +311,550 | Add 166.25% | 498,950 | $77.99 |
| Q3 2024 | -498,950 | Sold Out | 498,950 | $0.00 |
| Q4 2024 | +1.07 M | New Buy | 1.07 M | $65.52 |
| Q1 2025 | +114,042 | Add 10.62% | 1.19 M | $73.50 |
| Q2 2025 | +497,879 | Add 41.92% | 1.69 M | $69.88 |
| Q3 2025 | -1.12 M | Reduce 66.22% | 569,369 | $76.72 |
Steven Cohen's AstraZeneca PLC Investment FAQs
Steven Cohen first purchased AstraZeneca PLC (AZN) in Q2 2014, acquiring 741,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held AstraZeneca PLC (AZN) for 46 quarters since Q2 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's largest addition to AstraZeneca PLC (AZN) was in Q4 2020, adding 4,238,298 shares worth $211.87 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 569,369 shares of AstraZeneca PLC (AZN), valued at approximately $43.68 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, AstraZeneca PLC (AZN) represents approximately 0.07% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's peak holding in AstraZeneca PLC (AZN) was 4,811,660 shares, as reported at the end of Q3 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.